EchoSolv AS vs HealthCCSng

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoSolv AS

by Echo IQ

HealthCCSng

by Nano-X AI

AI Verdict

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis by analyzing echocardiogram measurements. In contrast, HealthCCSng focuses on detecting and quantifying coronary artery calcification from routine CT scans to assess coronary artery disease risk. While both are AI-powered cardiology tools, they address distinct cardiovascular conditions and utilize different imaging modalities, making them suitable for different clinical diagnostic pathways.

Choose EchoSolv AS if…

Choose EchoSolv AS if your primary goal is to enhance the accurate and rapid identification of patients at high risk for severe aortic stenosis (sAS) using existing echocardiogram measurements. This tool is ideal for cardiology departments and echocardiography labs seeking an AI-powered second reader or prioritization support to streamline the review of echo studies for sAS, integrating seamlessly into current PACS workflows without requiring EMR integration.

View EchoSolv AS →

Choose HealthCCSng if…

Choose HealthCCSng if you aim to proactively assess and quantify coronary artery disease (CAD) risk by leveraging routine, non-gated chest CT scans that may have been ordered for other indications. This solution is best suited for radiology and cardiology practices looking to automatically detect and score coronary artery calcification (CAC), providing valuable insights into a patient's cardiovascular health and integrating directly with PACS and EMR systems for an automated workflow.

View HealthCCSng →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoSolv AS	HealthCCSng
Pricing	Unknown	Not publicly available
Deployment	Cloud-based	Cloud-based, integrates with PACS and EMR systems
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

EchoSolv AS emphasizes fitting into existing workflows with 'no EMR integration required' and 'ultra-fast risk detection (under 3 seconds)', suggesting a lower barrier to adoption and immediate ease of use. Its measurement-based AI may also be more straightforward for clinicians to interpret.

Clinical Value

HealthCCSng

HealthCCSng offers significant clinical value by leveraging routine, non-contrast, non-ECG gated CT scans to detect and quantify coronary artery calcification (CAC), enabling opportunistic screening for coronary artery disease. This broadens the scope of early detection for a prevalent condition by utilizing existing imaging data.

Pricing & Value

Tie

Neither EchoSolv AS nor HealthCCSng provides publicly available pricing information in the structured facts or through general web searches. Both require direct vendor contact for pricing details, making a comparative assessment of their value proposition based on cost impossible.

Enterprise Readiness

HealthCCSng

HealthCCSng explicitly states 'seamless integration with PACS and EMR systems', indicating a more comprehensive and deeply embedded solution for enterprise environments. While Tool A integrates with PACS, full EMR integration (as offered by Tool B) is often crucial for robust data flow and workflow automation in large healthcare systems.

Innovation

HealthCCSng

HealthCCSng demonstrates significant innovation by automatically detecting and quantifying CAC from routine, non-contrast, non-ECG gated chest CT scans. This repurposes existing imaging data for opportunistic screening of coronary artery disease, offering a novel approach to population health.

Support & Docs

Tie

The provided structured facts and general web searches do not offer sufficient comparative details regarding the specific nature, quality, or availability of support and documentation for either EchoSolv AS or HealthCCSng. Without this information, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoSolv AS	HealthCCSng
Name	EchoSolv AS	HealthCCSng
Company	Echo IQ	Nano-X AI
Description	EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows.	HealthCCSng is an FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.
Primary Clinical Focus	Severe Aortic Stenosis (sAS) probability from echocardiograms	Coronary Artery Calcification (CAC) from CT scans
Key Feature Example	AI-powered clinical decision support for severe aortic stenosis probability	Automatically detects and quantifies coronary artery calcification (CAC)
Integration	Designed to fit existing workflows (no EMR integration required, integrates with PACS)	Seamless integration with PACS and EMR systems
Analysis Method	Measurement-based AI (analyzes numerical measurements, not images)	Analyzes non-contrast, non-ECG gated chest CT scans

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and HealthCCSng.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions do these AI tools help diagnose or assess?

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis (sAS) by analyzing echocardiograms. HealthCCSng, on the other hand, analyzes routine CT scans to detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.

What type of imaging data do these tools analyze?

EchoSolv AS analyzes numerical measurements derived from echocardiograms, rather than the images themselves, and does not use LVOT measurements. HealthCCSng analyzes non-contrast, non-ECG gated chest CT scans.

How do these tools integrate into existing clinical workflows?

EchoSolv AS is designed to fit existing workflows and integrates with PACS, without requiring EMR integration. HealthCCSng offers seamless integration with both PACS and EMR systems.

What are the key outputs or insights provided by each AI solution?

EchoSolv AS provides AI-powered clinical decision support for severe AS probability, a consistent guideline check from measurements, and second reader support to help prioritize studies. HealthCCSng automatically detects and quantifies CAC, generates a numerical calcium score, categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, and provides visualization of calcified plaques.

Which medical specialties are these tools most relevant for?

EchoSolv AS is primarily relevant for Cardiology and Cardiothoracic Surgery. HealthCCSng is primarily relevant for Cardiology and Radiology.

Do these tools require specific or specialized imaging protocols?

EchoSolv AS analyzes routine echocardiogram measurements and is designed not to use LVOT measurements. HealthCCSng analyzes routine non-contrast, non-ECG gated chest CT scans, leveraging existing scans that include the heart.